Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 167,347 | 99,814 | 190,514 | 88,952 | 88,609 |
| Marketable Securities | 315,569 | 121,613 | 10,493 | 11,997 | 3,503 |
| Receivables | 5,515 | N/A | 500 | N/A | N/A |
| TOTAL | $494,323 | $227,089 | $205,196 | $102,596 | $93,323 |
| Non-Current Assets | |||||
| PPE Net | 32,308 | 11,419 | 5,125 | 2,550 | 1,579 |
| Investments And Advances | 0 | 39,440 | 0 | 0 | 0 |
| Other Non-Current Assets | 95,826 | 24,326 | 2,711 | 146 | 146 |
| TOTAL | $128,134 | $75,185 | $7,836 | $2,696 | $1,725 |
| Total Assets | $622,457 | $302,274 | $213,032 | $105,292 | $95,048 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,438 | N/A | 8,187 |
| Accounts payable and accrued liabilities | 6,283 | 5,822 | 4,205 | 1,678 | 934 |
| Accrued Expenses | 15,564 | 14,697 | 10,926 | 7,254 | 3,957 |
| Other current liabilities | 39,218 | 2,808 | 2,106 | 12 | 4 |
| TOTAL | $85,564 | $27,806 | $27,263 | $11,049 | $15,187 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 12,446 | 14,808 | 2,501 |
| Deferred Revenues | 21,144 | 2,787 | 7,588 | 2,105 | 2,105 |
| Other Non-Current Liabilities | 106,427 | 25,937 | 5,354 | 1,522 | 1,377 |
| TOTAL | $152,448 | $29,712 | $25,300 | $17,054 | $6,707 |
| Total Liabilities | $238,012 | $57,518 | $52,563 | $28,103 | $21,894 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,783 | 75,931 | 65,000 | 52,769 | 41,387 |
| Common Shares | 88 | 76 | 65 | 53 | 41 |
| Retained earnings | -556,932 | -383,545 | -285,396 | -218,798 | -175,846 |
| Other shareholders' equity | 73 | 25 | 1 | 0 | 2 |
| TOTAL | $384,445 | $244,756 | $160,469 | $77,189 | $73,154 |
| Total Liabilities And Equity | $622,457 | $302,274 | $213,032 | $105,292 | $95,048 |